Invention Grant
- Patent Title: Anti-tofacitinib antibodies and uses thereof for drug monitoring
- Patent Title (中): 抗替芬替尼抗体及其用于药物监测的用途
-
Application No.: US14411356Application Date: 2013-06-18
-
Publication No.: US09408922B2Publication Date: 2016-08-09
- Inventor: Joseph Paul Gardner, II , Victoria Yatsum Wong
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agency: Pfizer Patent Department
- Agent Raquel M. Alvarez
- International Application: PCT/IB2013/055008 WO 20130618
- International Announcement: WO2014/001967 WO 20140103
- Main IPC: C07K16/44
- IPC: C07K16/44 ; A61K47/48 ; G01N33/94
Abstract:
The invention provides selective tofacitinib antibodies, immunogenic tofacitinib conjugates that are useful as immunogenic molecules for the generation of antibodies specific for tofacitinib, along with methods for measuring the concentration of tofacitinib in a sample, processes for making the antibodies, and assays and kits for using the antibodies.
Public/Granted literature
- US20150337054A1 ANTI-TOFACITINIB ANTIBODIES AND USES THEREOF FOR DRUG MONITORING Public/Granted day:2015-11-26
Information query
